McReynolds CB

References (12)

Title : Randomized, double-blind, phase 1a single-ascending dose and food effect studies assessing safety and pharmacokinetics of EC5026 in healthy volunteers - Schmidt_2024_Clin.Transl.Sci_17_e70033
Author(s) : Schmidt WK , Cortes-Puch I , McReynolds CB , Croston GE , Hwang SH , Yang J , Pedersen TL , Wagner KM , Pham TT , Hunt T , Hammock BD
Ref : Clin Transl Sci , 17 :e70033 , 2024
Abstract :
PubMedSearch : Schmidt_2024_Clin.Transl.Sci_17_e70033
PubMedID: 39300734

Title : Preclinical Evaluation of Soluble Epoxide Hydrolase Inhibitor AMHDU against Neuropathic Pain - Babkov_2024_Int.J.Mol.Sci_25_8841
Author(s) : Babkov D , Eliseeva N , Adzhienko K , Bagmetova V , Danilov D , McReynolds CB , Morisseau C , Hammock BD , Burmistrov V
Ref : Int J Mol Sci , 25 :8841 , 2024
Abstract :
PubMedSearch : Babkov_2024_Int.J.Mol.Sci_25_8841
PubMedID: 39201526
Gene_locus related to this paper: human-EPHX2

Title : The soluble epoxide hydrolase inhibitor TPPU improves comorbidity of chronic pain and depression via the AHR and TSPO signaling - Luo_2023_J.Transl.Med_21_71
Author(s) : Luo A , Wu Z , Li S , McReynolds CB , Wang D , Liu H , Huang C , He T , Zhang X , Wang Y , Liu C , Hammock BD , Hashimoto K , Yang C
Ref : J Transl Med , 21 :71 , 2023
Abstract :
PubMedSearch : Luo_2023_J.Transl.Med_21_71
PubMedID: 36732752

Title : sEH-derived metabolites of linoleic acid drive pathologic inflammation while impairing key innate immune cell function in burn injury - Bergmann_2022_Proc.Natl.Acad.Sci.U.S.A_119_e2120691119
Author(s) : Bergmann CB , McReynolds CB , Wan D , Singh N , Goetzman H , Caldwell CC , Supp DM , Hammock BD
Ref : Proc Natl Acad Sci U S A , 119 :e2120691119 , 2022
Abstract :
PubMedSearch : Bergmann_2022_Proc.Natl.Acad.Sci.U.S.A_119_e2120691119
PubMedID: 35312372

Title : Species Differences in Metabolism of Soluble Epoxide Hydrolase Inhibitor, EC1728, Highlight the Importance of Clinically Relevant Screening Mechanisms in Drug Development - McReynolds_2021_Molecules_26_
Author(s) : McReynolds CB , Yang J , Guedes A , Morisseau C , Garcia R , Knych H , Tearney C , Hamamoto B , Hwang SH , Wagner K , Hammock BD
Ref : Molecules , 26 : , 2021
Abstract :
PubMedSearch : McReynolds_2021_Molecules_26_
PubMedID: 34443621

Title : Plasma Linoleate Diols Are Potential Biomarkers for Severe COVID-19 Infections - McReynolds_2021_Front.Physiol_12_663869
Author(s) : McReynolds CB , Cortes-Puch I , Ravindran R , Khan IH , Hammock BG , Shih PB , Hammock BD , Yang J
Ref : Front Physiol , 12 :663869 , 2021
Abstract :
PubMedSearch : McReynolds_2021_Front.Physiol_12_663869
PubMedID: 33868029

Title : Movement to the Clinic of Soluble Epoxide Hydrolase Inhibitor EC5026 as an Analgesic for Neuropathic Pain and for Use as a Nonaddictive Opioid Alternative - Hammock_2021_J.Med.Chem__
Author(s) : Hammock BD , McReynolds CB , Wagner K , Buckpitt A , Cortes-Puch I , Croston G , Lee KSS , Yang J , Schmidt WK , Hwang SH
Ref : Journal of Medicinal Chemistry , : , 2021
Abstract :
PubMedSearch : Hammock_2021_J.Med.Chem__
PubMedID: 33550801

Title : Development of Improved Double Nanobody Sandwich ELISAs for Human Soluble Epoxide Hydrolase Detection in PBMCs of Diabetic and Pre-frontal Cortex of Multiple Sclerosis Patients - Li_2020_Anal.Chem_92_7334
Author(s) : Li D , Morisseau C , McReynolds CB , Duflot T , Bellien J , Nagra RM , Taha AY , Hammock BD
Ref : Analytical Chemistry , 92 :7334 , 2020
Abstract :
PubMedSearch : Li_2020_Anal.Chem_92_7334
PubMedID: 32253910

Title : Soluble Epoxide Hydrolase Regulation of Lipid Mediators Limits Pain - Wagner_2020_Neurotherapeutics_17_900
Author(s) : Wagner KM , Gomes A , McReynolds CB , Hammock BD
Ref : Neurotherapeutics , 17 :900 , 2020
Abstract :
PubMedSearch : Wagner_2020_Neurotherapeutics_17_900
PubMedID: 32875445

Title : In vitro and in vivo Metabolism of a Potent Inhibitor of Soluble Epoxide Hydrolase, 1-(1-Propionylpiperidin-4-yl)-3-(4-(trifluoromethoxy)phenyl)urea - Wan_2019_Front.Pharmacol_10_464
Author(s) : Wan D , Yang J , McReynolds CB , Barnych B , Wagner KM , Morisseau C , Hwang SH , Sun J , Blocher R , Hammock BD
Ref : Front Pharmacol , 10 :464 , 2019
Abstract :
PubMedSearch : Wan_2019_Front.Pharmacol_10_464
PubMedID: 31143115

Title : Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis - McReynolds_2019_Front.Pharmacol_10_533
Author(s) : McReynolds CB , Hwang SH , Yang J , Wan D , Wagner K , Morisseau C , Li D , Schmidt WK , Hammock BD
Ref : Front Pharmacol , 10 :533 , 2019
Abstract :
PubMedSearch : McReynolds_2019_Front.Pharmacol_10_533
PubMedID: 31214021

Title : Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases - Wagner_2017_Pharmacol.Ther_180_62
Author(s) : Wagner KM , McReynolds CB , Schmidt WK , Hammock BD
Ref : Pharmacol Ther , 180 :62 , 2017
Abstract :
PubMedSearch : Wagner_2017_Pharmacol.Ther_180_62
PubMedID: 28642117